224 related articles for article (PubMed ID: 30839985)
1. In situ hydrogelation of bicalutamide-peptide conjugates at prostate tissue for smart drug release based on pH and enzymatic activity.
He S; Mei L; Wu C; Tao M; Zhai Z; Xu K; Zhong W
Nanoscale; 2019 Mar; 11(11):5030-5037. PubMed ID: 30839985
[TBL] [Abstract][Full Text] [Related]
2. In situ hydrogelation of forky peptides in prostate tissue for drug delivery.
Tao M; Liu J; He S; Xu K; Zhong W
Soft Matter; 2019 May; 15(20):4200-4207. PubMed ID: 31070656
[TBL] [Abstract][Full Text] [Related]
3. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract][Full Text] [Related]
4. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
5. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.
Danquah M; Fujiwara T; Mahato RI
Biomaterials; 2010 Mar; 31(8):2358-70. PubMed ID: 20018369
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
7. The conjugates of forky peptides and nonsteroidal anti-inflammatory drugs (NSAID) self-assemble into supramolecular hydrogels for prostate cancer-specific drug delivery.
Tao M; He S; Liu J; Li H; Mei L; Wu C; Xu K; Zhong W
J Mater Chem B; 2019 Jan; 7(3):469-476. PubMed ID: 32254734
[TBL] [Abstract][Full Text] [Related]
8. Polyion complex hydrogels from chemically modified cellulose nanofibrils: Structure-function relationship and potential for controlled and pH-responsive release of doxorubicin.
Hujaya SD; Lorite GS; Vainio SJ; Liimatainen H
Acta Biomater; 2018 Jul; 75():346-357. PubMed ID: 29885527
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery.
Casolaro M; Casolaro I; Lamponi S
Eur J Pharm Biopharm; 2012 Apr; 80(3):553-61. PubMed ID: 22138000
[TBL] [Abstract][Full Text] [Related]
10. Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized "smart" drug release.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2018 May; 72():55-69. PubMed ID: 29555459
[TBL] [Abstract][Full Text] [Related]
11. Bioflavonoid hesperetin overcome bicalutamide induced toxicity by co-delivery in novel SNEDDS formulations: Optimization, in vivo evaluation and uptake mechanism.
Arya A; Ahmad H; Tulsankar S; Agrawal S; Mittapelly N; Boda R; Bhatta RS; Mitra K; Dwivedi AK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():954-964. PubMed ID: 27987794
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery.
Mei L; Xu K; Zhai Z; He S; Zhu T; Zhong W
Org Biomol Chem; 2019 Apr; 17(15):3853-3860. PubMed ID: 30938396
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging.
Parent EE; Dence CS; Jenks C; Sharp TL; Welch MJ; Katzenellenbogen JA
J Med Chem; 2007 Mar; 50(5):1028-40. PubMed ID: 17328524
[TBL] [Abstract][Full Text] [Related]
14. Non-proteinogenic amino acid based supramolecular hydrogel material for enhanced cell proliferation.
Arokianathan JF; Ramya KA; Janeena A; Deshpande AP; Ayyadurai N; Leemarose A; Shanmugam G
Colloids Surf B Biointerfaces; 2020 Jan; 185():110581. PubMed ID: 31677412
[TBL] [Abstract][Full Text] [Related]
15. Zinc-ion-mediated self-assembly of forky peptides for prostate cancer-specific drug delivery.
Tao M; Xu K; He S; Li H; Zhang L; Luo X; Zhong W
Chem Commun (Camb); 2018 May; 54(37):4673-4676. PubMed ID: 29675529
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.
Altimari JM; Niranjan B; Risbridger GP; Schweiker SS; Lohning AE; Henderson LC
Bioorg Med Chem Lett; 2014 Nov; 24(21):4948-53. PubMed ID: 25301770
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment.
Wang Q; Sun C; Xu B; Tu J; Shen Y
Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cells.
Quéro L; Giocanti N; Hennequin C; Favaudon V
Prostate; 2010 Mar; 70(4):401-11. PubMed ID: 19902473
[TBL] [Abstract][Full Text] [Related]
19. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
20. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
